Subscribe for daily wellness inspiration

Like onlymyhealth on Facebook!

What is the Prognosis of Dyssynergia Cerebellaris Myoclonica?

By  ,  Onlymyhealth editorial team
Dec 11, 2014
4.8 / 5(4 Ratings)
Quick Bites

  • It is a collection of rare disorders.
  • The onset occurs in early childhood.
  • In some cases condition occurs due to mitochondrial abnormalities.
  • Progression is usually for 10 year and even more.

More

What is Dyssynergia Cerebellaris Myoclonica?

A collection of rare, degenerative, neurological disorders which are characterized by epilepsy, cognitive impairment, myoclonus and progressive ataxia is known as Dyssynergia Cerebellaris Myoclonica. The onset of the disorder generally occurs in early adulthood. The tremor may start in one extremity and later spread to involve the whole voluntary muscular system. Usually, arms get more affected that legs. In some cases, the condition also occurs because of mitochondrial abnormalities.

Dyssynergia Cerebellaris Myoclonica Prognosis

Treatment for Dyssynergia Cerebellaris Myoclonica

The treatment for Dyssynergia Cerebellaris Myoclonica is symptomatic. Myoclonus and seizures can be treated with drugs like valproate.

Dyssynergia Cerebellaris Myoclonica Prognosis

What is the Prognosis for Dyssynergia Cerebellaris Myoclonica?

The progression for this condition is normally 10 years or even more than that.

Image courtesy: Getty Images

Read more on Dyssynergia Cerebellaris Myoclonica Diagnosis and Prognosis.

Related Articles
4.8 / 5(4 Ratings)
Write a Review
Post a Comment
Disclaimer +
Though all possible measures have been taken to ensure accuracy, reliability, timeliness and authenticity of the information; Onlymyhealth assumes no liability for the same. Using any information of this website is at the viewers’ risk. Please be informed that we are not responsible for advice/tips given by any third party in form of comments on article pages . If you have or suspect having any medical condition, kindly contact your professional health care provider.